Yesterday shares of pharmaceutical companies working on a drug to treat Ebola spiked after the Centre for Disease Control and Prevention(CDC) confirmed the first case of the illness diagnosed in the United States.
Now we have a Chimera in action whereby shares rise on companies that control vaccines and vaccines are controlled by supply and demand, thus pushing up prices to the US Government and also lining the pockets of the owners of patents and their shareholding.
This is just the beginning and not the end as more companies now know how to control the share-markets, at the expense of the people, whilst using scare tactics effectively, and keeping this going for ever and a day.
The United States now has one confirmed case of Ebola, the Centers for Disease Control and Prevention said on Tuesday, marking the first domestic appearance of the deadly virus that has ravaged swaths of continental Africa.
‘ First Case of Ebola in US Pushes Shares Upward ‘
The as-yet unidentified patient is located in Dallas, officials say, effectively confirming a statement issued on Monday by Texas Health Presbyterian Hospital of Dallas. The organization said that an unnamed patient was being tested for Ebola and had been placed in “strict isolation” due to the patient’s symptoms and recent travel history.
In a press conference, CDC Director Tom Frieden said the patient in question had been traveling in Liberia, where he may have contracted the disease. He returned to the United States on the 20th of September, after which he sought care.
Frieden attempted to assuage concerns about Ebola’s contagious effect, saying that the virus was only spread through direct contact, and was not airborne.
He vowed that officials would contain a potential spread.
“It is certainly possible that someone who had contact with this individual…could develop Ebola in the coming weeks,” Frieden said, but added that “there is no doubt in my mind that we will stop it here,” Frieden said.